Point72 Asia (Singapore)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,326	Closed	-$186K	–	1079
2024 Q2	$186K	Sell	14,326 -10,884	-43%	-$141K	0.04%	315
2024 Q1	$440K	Buy	25,210 +24,010	+2,001%	+$419K	0.11%	185
2023 Q4	$11.3K	Buy	+1,200	New	+$11.3K	﹤0.01%	494